MESA LABORATORIES INC
MLABNASDAQTrading Snapshot
- Day Range
- $129.78 – $132.04
- 52-Week Range
- $63.48 – $138.66
- Volume
- $1.83B
- Avg Volume
- $1.73B
- Shares Outstanding
- 5.6M
- Next Earnings
- Dec 15, 2026
Fundamentals Snapshot
- Annual Revenue
- $249M
- Last Q Revenue
- $60M
- P/E Ratio
- 155.9
- P/S Ratio
- 3.0x
- EPS (TTM)
- $0.85
- Dividend Yield
- 0.48%
- Dilution (1yr)
- +3.5%
Why Investors Own MLAB
- ✓High-growth profile — revenue up +38.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 53% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MESA LABORATORIES INC
MLAB
StockOtter · stockotter.spaceAbout MESA LABORATORIES INC
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
MESA LABORATORIES INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift MLAB price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
MESA LABORATORIES INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.